Rigel Pharmaceuticals, Inc.
RIGL NASDAQ







Weekly Report
Rigel Pharmaceuticals, Inc. closed at 34.7200 (-0.32% WoW) . Data window ends Fri, 19 Sep 2025.
How to read this โ Price slope is upward, indicating persistent buying over the window. Volume trend diverges from price โ watch for fatigue or rotation. Returns are negatively correlated with volume โ strength may come on lighter activity. Constructive MA stack supports the up-drift; pullbacks may find support at the 8โ13 week region.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm. Because liquidity isnโt confirming, prefer evidence of fresh demand before chasing moves.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Gauge is elevated but momentum is rolling over; topping risk is rising. Notable breakdown from โฅ0.80 weakens trend quality.
Stay alert: protect gains or seek confirmation before adding risk.
The flag is positive: favourable upside skew with supportive conditions.
Conclusion
Negative setup. โ โ โโโ confidence. Price window: 58. Trend: Uptrend at Risk; gauge 82. In combination, liquidity diverges from price.
- Momentum is bullish and rising
- Constructive moving-average stack
- Solid multi-week performance
- High-level but rolling over (topping risk)
- Price is not above key averages
- Liquidity diverges from price
- Sellers active at elevated levels (distribution)
Why: Price window 58.47% over 8w. Close is -16.01% below the prior-window high. Volume trend falling. Liquidity divergence with price. Trend state uptrend at risk. High-regime (0.80โ1.00) downticks 1/2 (50.0%) โข Accumulating. MA stack constructive. Baseline deviation 1.24% (widening). Momentum bullish and rising. Valuation stance positive.
Tip: Most metrics include a hover tooltip where they appear in the report.